Skip to main content

Myovant Sciences Ltd.

MYOVDelisted Mar 10, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001679082

Myovant Sciences Ltd. was delisted on Mar 10, 2023; its insiders filed their last Form 4 on Mar 10, 2023; 118 institutions reported holding it in 13F filings for Q4 2022, worth $1.12B in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Myovant Sciences Ltd. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Myovant Sciences Ltd., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Myovant Sciences Ltd.
NameTitleLast reported holdingLast filingFilings, past year
Sumitomo Pharma Co., Ltd.10% Owner45,798,176IndirectMar 10, 20230
Sumitovant Biopharma Ltd.10% Owner45,798,176IndirectMar 10, 20230
Sumitomo Chemical Co., Ltd.10% Owner45,798,176IndirectMar 10, 20230
Potter Myrtle SDirector0Mar 10, 20230
Guinan MarkDirector0Mar 10, 20230
Marek David CPrincipal Executive Officer0Mar 10, 20230
Gulfo Adele M.Director0Mar 10, 20230
Curran TerrieDirector0Mar 10, 20230
Lang MatthewGeneral Counsel & Corp. Secy.0Mar 10, 20230
Arjona Ferreira Juan CamiloChief Medical Officer0Mar 10, 20230
Merendino LaurenChief Commercial Officer0Mar 10, 20230
Mehra UneekPrincipal Financial Officer0Mar 10, 20230
Valente NancyDirector0Mar 10, 20230
Karbe FrankPrincipal Fin'l & Accounting212,296Jul 9, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 9, 2021 (view filing)Jul 72 daysKarbe FrankPrincipal Fin'l & AccountingSSale−3.23K$21.75−$70.3K−1.5%212.3K after
Jul 9, 2021 (view filing)Jul 72 daysArjona Ferreira Juan CamiloChief Medical OfficerSSale−2.78K$21.75−$60.4K−1.6%173.3K after
Jul 13, 2021 (view filing)Jul 94 daysLang MatthewGeneral Counsel & Corp. Secy.SSale−6.95K$21.52−$149.7K−3.6%186.5K after
Aug 18, 2021 (view filing)5:05 PM ETAug 16-172 daysSumitomo Pharma Co., Ltd. and 2 others10% OwnerPPurchase+71.7K$21.21+$1.52M+0.1%48.7M after3 lots
Aug 20, 2021 (view filing)5:00 PM ETAug 18-192 daysSumitomo Pharma Co., Ltd. and 2 others10% OwnerPPurchase+63.9K$21.49+$1.37M+0.1%48.8M after2 lots
Aug 24, 2021 (view filing)5:00 PM ETAug 20-234 daysSumitomo Pharma Co., Ltd. and 2 others10% OwnerPPurchase+101.9K$21.65+$2.21M+0.2%48.9M after3 lots
Aug 26, 2021 (view filing)5:00 PM ETAug 24-252 daysSumitomo Pharma Co., Ltd. and 2 others10% OwnerPPurchase+63.0K$22.40+$1.41M+0.1%48.9M after2 lots
Aug 30, 2021 (view filing)5:00 PM ETAug 26-274 daysSumitomo Pharma Co., Ltd. and 2 others10% OwnerPPurchase+77.0K$22.91+$1.77M+0.2%49.0M after2 lots
Aug 31, 2021 (view filing)Aug 27-304 daysArjona Ferreira Juan CamiloChief Medical OfficerSSale−23.0K$23.93−$549.9K−11.8%171.3K after2 lots
Sep 1, 2021 (view filing)5:00 PM ETAug 30-312 daysSumitomo Pharma Co., Ltd. and 2 others10% OwnerPPurchase+109.0K$24.05+$2.62M+0.2%49.1M after2 lots
Sep 3, 2021 (view filing)Sep 1-22 daysCurran TerrieDirectorSSale−48.5K$25.02−$1.21M−100.0%0 after2 lots
Sep 3, 2021 (view filing)5:00 PM ETSep 1-22 daysSumitomo Pharma Co., Ltd. and 2 others10% OwnerPPurchase+103.1K$25.60+$2.64M+0.2%49.2M after4 lots
Sep 8, 2021 (view filing)5:00 PM ETSep 3-75 daysSumitomo Pharma Co., Ltd. and 2 others10% OwnerPPurchase+64.4K$26.49+$1.71M+0.1%49.3M after4 lots
Sep 10, 2021 (view filing)5:00 PM ETSep 8-92 daysSumitomo Pharma Co., Ltd. and 2 others10% OwnerPPurchase+58.9K$25.60+$1.51M+0.1%49.4M after2 lots
Sep 13, 2021 (view filing)Sep 94 daysCurran TerrieDirectorSSale−4.85K$25.58−$124.1K−100.0%0 after
Sep 14, 2021 (view filing)5:00 PM ETSep 10-134 daysSumitomo Pharma Co., Ltd. and 2 others10% OwnerPPurchase+113.2K$23.84+$2.70M+0.2%49.5M after3 lots
Sep 16, 2021 (view filing)5:00 PM ETSep 14-152 daysSumitomo Pharma Co., Ltd. and 2 others10% OwnerPPurchase+161.2K$22.03+$3.55M+0.3%49.6M after3 lots
Sep 20, 2021 (view filing)5:00 PM ETSep 16-174 daysSumitomo Pharma Co., Ltd. and 2 others10% OwnerPPurchase+87.9K$22.20+$1.95M+0.2%49.7M after2 lots
Sep 22, 2021 (view filing)5:00 PM ETSep 20-212 daysSumitomo Pharma Co., Ltd. and 2 others10% OwnerPPurchase+81.3K$22.30+$1.81M+0.2%49.8M after2 lots
Sep 24, 2021 (view filing)5:00 PM ETSep 22-232 daysSumitomo Pharma Co., Ltd. and 2 others10% OwnerPPurchase+138.8K$22.39+$3.11M+0.3%49.9M after3 lots
Sep 28, 2021 (view filing)5:00 PM ETSep 24-274 daysSumitomo Pharma Co., Ltd. and 2 others10% OwnerPPurchase+84.0K$23.87+$2.00M+0.2%50.0M after3 lots
Sep 29, 2021 (view filing)Sep 272 daysArjona Ferreira Juan CamiloChief Medical OfficerSSale−7.00K$24.32−$170.2K−3.9%171.3K after
Sep 30, 2021 (view filing)5:00 PM ETSep 282 daysSumitomo Pharma Co., Ltd. and 2 others10% OwnerPPurchase+20.7K$22.85+$472.4K0.0%50.0M after
Oct 7, 2021 (view filing)Oct 52 daysLang MatthewGeneral Counsel & Corp. Secy.SSale−6.67K$21.62−$144.2K−3.6%179.8K after
Oct 7, 2021 (view filing)Oct 52 daysArjona Ferreira Juan CamiloChief Medical OfficerSSale−2.74K$21.62−$59.2K−1.6%168.6K after
Nov 5, 2021 (view filing)Nov 3-42 daysArjona Ferreira Juan CamiloChief Medical OfficerSSale−3.80K$24.02−$91.3K−2.2%168.6K after2 lots
Dec 1, 2021 (view filing)Nov 292 daysArjona Ferreira Juan CamiloChief Medical OfficerSSale−1.98K$19.30−$38.2K−1.2%166.6K after
Jan 6, 2022 (view filing)Jan 42 daysArjona Ferreira Juan CamiloChief Medical OfficerSSale−2.27K$16.27−$36.9K−1.4%164.3K after
Jan 6, 2022 (view filing)Jan 42 daysLang MatthewGeneral Counsel & Corp. Secy.SSale−4.47K$16.27−$72.8K−2.5%175.4K after
Jan 21, 2022 (view filing)Jan 192 daysMarek David CPrincipal Executive OfficerSSale−19.9K$14.68−$291.9K−5.6%338.0K after
Mar 3, 2022 (view filing)Mar 12 daysArjona Ferreira Juan CamiloChief Medical OfficerSSale−1.36K$13.35−$18.2K−0.8%163.0K after
Apr 7, 2022 (view filing)Apr 52 daysArjona Ferreira Juan CamiloChief Medical OfficerSSale−1.92K$13.78−$26.5K−1.2%161.1K after
Apr 7, 2022 (view filing)Apr 52 daysLang MatthewGeneral Counsel & Corp. Secy.SSale−2.44K$13.78−$33.6K−1.4%172.9K after
Apr 21, 2022 (view filing)Apr 192 daysMarek David CPrincipal Executive OfficerSSale−24.6K$10.45−$257.0K−5.2%448.0K after
Apr 21, 2022 (view filing)Apr 192 daysMerendino LaurenChief Commercial OfficerSSale−7.05K$10.45−$73.7K−3.9%175.0K after
Apr 21, 2022 (view filing)Apr 192 daysArjona Ferreira Juan CamiloChief Medical OfficerSSale−4.63K$10.45−$48.4K−1.7%260.1K after
Apr 21, 2022 (view filing)Apr 192 daysLang MatthewGeneral Counsel & Corp. Secy.SSale−8.00K$10.45−$83.6K−2.8%276.0K after
Jun 1, 2022 (view filing)May 275 daysArjona Ferreira Juan CamiloChief Medical OfficerSSale−1.38K$10.07−$13.9K−0.5%258.7K after
Jul 8, 2022 (view filing)Jul 62 daysLang MatthewGeneral Counsel & Corp. Secy.SSale−3.70K$13.40−$49.6K−1.3%272.3K after
Jul 8, 2022 (view filing)Jul 62 daysArjona Ferreira Juan CamiloChief Medical OfficerSSale−2.75K$13.40−$36.9K−1.1%256.0K after
Jul 20, 2022 (view filing)Jul 182 daysArjona Ferreira Juan CamiloChief Medical OfficerSSale−1.61K$12.87−$20.7K−0.6%254.4K after
Jul 20, 2022 (view filing)Jul 182 daysMarek David CPrincipal Executive OfficerSSale−11.2K$12.87−$143.7K−2.5%436.8K after
Jul 20, 2022 (view filing)Jul 182 daysMerendino LaurenChief Commercial OfficerSSale−1.70K$12.87−$21.9K−1.0%173.2K after
Jul 20, 2022 (view filing)Jul 182 daysLang MatthewGeneral Counsel & Corp. Secy.SSale−1.94K$12.87−$24.9K−0.7%270.4K after
Aug 16, 2022 (view filing)Aug 151 dayLang MatthewGeneral Counsel & Corp. Secy.SSale−31.2K$18.23−$569.0K−7.9%364.0K after
Sep 20, 2022 (view filing)Sep 164 daysMehra UneekPrincipal Financial OfficerSSale−9.24K$18.86−$174.3K−4.3%204.9K after
Oct 6, 2022 (view filing)Oct 42 daysLang MatthewGeneral Counsel & Corp. Secy.SSale−3.68K$24.40−$89.8K−1.0%360.3K after
Oct 6, 2022 (view filing)Oct 42 daysArjona Ferreira Juan CamiloChief Medical OfficerSSale−2.74K$24.40−$66.8K−1.1%251.6K after
Oct 20, 2022 (view filing)Oct 182 daysArjona Ferreira Juan CamiloChief Medical OfficerSSale−1.60K$25.20−$40.4K−0.6%250.0K after
Oct 20, 2022 (view filing)Oct 182 daysLang MatthewGeneral Counsel & Corp. Secy.SSale−1.93K$25.20−$48.7K−0.5%358.4K after